Life science & clinical diagnostics instruments > Clinical chemistry systems/kits

Urine test for bladder cancer could replace cystoscopies

29 April, 2022

The test will use highly sensitive liquid biopsy technology, in conjunction with a panel of biomarkers, to detect the presence of bladder cancer.

Lab-on-a-strip test for dengue fever developed

22 April, 2022

Researchers have used a new diagnostic kit called Cygnus to detect dengue fever, with significantly improved rates over lateral flow testing kits.

'Lab in a backpack' enables portable COVID-19 testing

28 January, 2022

Costing just US$51 to make, the compact kit could offer a testing solution for areas with little access to well-equipped labs or trained personnel.

Rapid antigen tests available now, ATAGI approves boosters

01 November, 2021 by Lauren Davis

The TGA has approved a total of nine COVID-19 rapid antigen tests, while vaccine booster shots will be available to Australian adults from 8 November.

TGA supports at-home COVID-19 testing from 1 November

29 September, 2021 by Lauren Davis

At-home rapid antigen tests for COVID-19 will be available in Australia from 1 November 2021, subject to individual tests being approved as safe and effective.

Blood test monitors cancer treatment outcomes in real time

21 June, 2021

Cancer patients who are undergoing targeted therapy can look forward to a new blood test that could tell their doctors whether the treatment is working.

BioVision ExoPure Exosome Isolation Kits

04 March, 2021

BioVision's ExoPure Exome Isolation Kits offer a fast and convenient method of exosome isolation and purification at high yields with intact morphology from body fluids, cell media, serum and plasma, urine and stem cell media.

Rapid COVID-19 tests to be rolled out in Africa

30 October, 2020

The rollout of new, World Health Organization-approved, antigen-based rapid diagnostic tests for COVID-19 in Africa is expected to significantly boost testing capacity.

PixCell Medical HemoScreen haematology analyser

08 October, 2020

PixCell Medical has received regulatory approval from the Therapeutic Goods Administration (TGA) for its HemoScreen device, designed to make the most common complete blood count (CBC) test accessible locally when results are needed quickly.

Graphene oxide enables rapid infection detection

11 August, 2020

Researchers have developed a graphene oxide-based sensor platform to detect acute infections within minutes.

Breast cancer can be detected in your tears

20 July, 2020

TearExo is a chemical nanoprocessing technology that detects breast cancer using the exosomes found in small amounts of bodily fluids, such as tears, as biomarkers.

QIAGEN QIAstat-Dx syndromic testing instrument

01 April, 2019

Using direct swab or liquid transfer, the QIAstat-Dx provides results for 20+ respiratory or gastrointestinal pathogens in about 1 h, with less than 1 min of hands-on time.

CD-style device to detect antibiotic allergies

12 March, 2019

A newly developed biophotonic system makes it possible to detect, in a non-invasive way and with a very small sample of blood, allergies to antibiotics in less than an hour.

Blood collection tube coated in Taipan venom

08 June, 2017

Q-Sera has developed a blood collection tube which rapidly produces high-quality serum for testing. The secret to the company's success? Proteins sourced from the venom of the Australian Coastal Taipan.

Sysmex UF-5000 Urine Analyser

01 June, 2017

Sysmex recently launched the UF-5000 flow cytometry system to measure the formed elements in urine samples.

  • All content Copyright © 2022 Westwick-Farrow Pty Ltd